About this trial
The goal of this clinical trial is to learn whether PSYCHOPATHY.COMP, an individual compassion-focused, therapy-based intervention of 20 weekly sessions, can reduce psychopathy in prison inmates. Psychopathy is linked with the most severe and persistent forms of antisocial behavior. This trial will also learn whether the program improves emotional and behavioral regulation.
The main questions are:
* Does PSYCHOPATHY.COMP reduce psychopathy? * Does PSYCHOPATHY.COMP improve emotional and behavioral regulation? Researchers will compare PSYCHOPATHY.COMP with the usual individual case management support provided in prisons.
Portuguese-speaking adult male prison inmates will be invited to participate. Those who consent to participate will be screened for inclusion (T0). A total of 200 eligible participants will take part. All participants will be invited to complete a baseline assessment (T1, pre-treatment assessment), after which they will be randomly assigned to receive PSYCHOPATHY.COMP or the usual care provided in the prison for a period of around six months. All participants will be invited to complete a post-treatment assessment (T2) and a six-month follow-up assessment post-treatment. Assessments will collect data on sociodemographic characteristics and legal/criminal information, psychological outcomes (psychopathy, emotional regulation, and behavioral regulation), psychological mediators (mechanisms of change: compassion-related variables), and moderators (personality pathology), and data on social desirability.
This study aims to contribute to advancing scientific knowledge about whether and how to reduce psychopathy among prison inmates and have an impact on clinical practice and society by making available evidence-based interventions to this at-risk/high-risk population.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
male prison inmates,
Portuguese-speaking,
aged between 19 and 30 years
having at least one prior case in the juvenile justice system in which a judicial measure was applied,
Disqualifiers
suspected psychotic/autism spectrum disorders and/or cognitive impairments,
female,
sentence length inferior to 24 months since the start of the study.
Trial design
Parallel
Treatments tested in this trial
PSYCHOPATHY.COMP
BehavioralParticipants allocated to the treatment group will receive PSYCHOPATHY.COMP. PSYCHOPATHY.COMP is a manualized intervention of 20 weekly 60-min sessions (\~6 months) rooted in Compassion Focused Therapy (CFT). PSYCHOPATHY.COMP follows a progressive strategy of change in four modules: (1) The basics of our mind; (2) Our mind according to CFT; (3) Compassionate Mind Training; and (4) Recovery, relapse and prevention. As a common feature of all therapeutic sessions, therapists are focused on developing a secure therapeutic relationship. PSYCHOPATHY.COMP is delivered by psychologists skilled in CFT (including those from prisons). Psychologists will be trained (through an intensive, face-to-face 5-day training) and supervised (one session/month) by the research team during the delivery of the intervention. During PSYCHOPATHY.COMP, participants will not receive individual therapy (psychotherapy, psychological treatment) by an accredited psychologist or therapist.
Treatment as Usual (TAU)
Other interventionParticipants in the control group will receive the routine support offered in the prison setting, tailored to individual case management and focused on behavioural management and adjustment.
Treatment groups
Trial outcomes
Primary outcomes
Efficacy Testing: change from eligibility assessment in participant-reported psychopathy (primary outcome) to six-month follow-up
Modified intention-to-treat (mITT, all participants randomized) and per protocol (PP, only participants who completed a sufficient dose) analyses of mean differences in participant-reported psychopathy between PSYCHOPATHY.COMP and TAU groups. Measured with the Self-Report Psychopathy Scale - Short-form (SRP-SF): a 29-item, shortened version of SRP-4 that assesses psychopathy according to the conceptualization of the Hare's Psychopathy Checklist - Revised. SRP-SF measures four facets of psychopathy: interpersonal (INT; 7 items), affective (AFF; 7 items), lifestyle (LIF; 7 items), and antisocial (ANT; 8 items). Items are rated on a five-point Likert-type scale, ranging from 1: "Strongly disagree" to 5: "Strongly agree". Total and subscale scores are computed by summing the corresponding individual item scores (after correcting for reversed items), with higher scores indicating higher levels of psychopathic traits.
Efficacy Testing: change from eligibility assessment in participant-reported psychopathy (primary outcome) to six-month follow-up
mITT and PP analyses of mean differences in participant-reported psychopathy between PSYCHOPATHY.COMP and TAU groups. Measured with the Levenson Self-Report Psychopathy Scale (LSRPS): a 26-item questionnaire assessing psychopathy in two domains: primary (selfish, callous, uncaring and manipulative; 16 items) and secondary (impulsivity and behavioural control; 10 items) psychopathy, which aligns with the conceptualization of the Hare's Psychopathy Checklist - Revised. Items are rated on a four-point Likert-type scale, ranging from 1: "Strongly disagree" to 4: "Strongly agree". Total and subscale scores are computed by summing the corresponding individual item scores (after correcting for reversed items), with higher scores indicating higher levels of psychopathy.
Secondary outcomes
Efficacy Testing: changes from baseline in participant-reported emotional regulation (secondary outcome) to six-month follow-up
mITT and PP analyses of mean differences in emotional regulation between PSYCHOPATHY.COMP and TAU groups. Measured with State-Trait Anger Expression Inventory (STAXI): 44-item self-report questionnaire assessing anger-state (how one feels in the present moment; 10 items), anger-trait (how one generally feels, 10 items; with two factors: temperament and angry reaction, 4 items each), and anger-expression (how one generally reacts or behaves when feeling enraged or angry, 24 items; three factors: anger expression-in, anger expression-out and anger control, 8 items each). Items are rated on a four-point Likert-type scale from 1: "Not at all/almost never" to 4: "Very much so/almost always". Scale scores are computed by summing item scores, higher scores indicate higher levels of anger. Anger Expression scale is calculated as the sum of Anger Expression-In and Anger Expression-Out minus Anger Control, plus a constant.
Efficacy Testing: changes from baseline in participant-reported emotional regulation (secondary outcome) to six-month follow-up
mITT and PP analyses of mean differences in participant-reported emotional regulation between PSYCHOPATHY.COMP and TAU groups. Measured with the Other As Shamer Scale - 2 (OAS-2), a shorter form of the Other as Shamer scale (OAS). OAS-2 is an 8-item self-report questionnaire measuring external shame (i.e., subject's perception of being negatively judged by others). Items are rated on a five-point Likert-type scale, ranging from 0: "Never" to 4: "Almost always". The scale scores are computed by summing the corresponding individual item scores, with higher scores indicating higher levels of shame.
Efficacy Testing: changes from eligibility in participant-reported behavioral regulation (secondary outcome) to six-month follow-up
mITT and PP analyses of mean differences in participant-reported behavioral regulation between PSYCHOPATHY.COMP and TAU groups. Measured with an institutional behavioral grid (IBG) developed by the research team and previously used. IBG assessed the number/type of disciplinary infractions and the number of days of the punitive measures applied by the prison administration (collected from individual prison record files).
Other outcomes
Mediation Testing: participant-reported compassion-related variables
mITT and PP analyses of mean differences in participant-reported emotional regulation between PSYCHOPATHY.COMP and TAU groups. Measured with the Self-Compassion Scale (SCS): a 26-item self-report questionnaire measuring six components (subscales) of self-compassion: self-kindness (5 items), self-judgment (5 items), common humanity (4 items), isolation (4 items), mindfulness (4 items), and overidentification (4 items). Items are rated on a five-point Likert-type scale, ranging from 1: "Almost never" to 5: "Almost always". Scores are computed by averaging item responses (after correcting for reversed items), with higher scores indicating higher levels of self-compassion.
Mediation Testing: participant-reported compassion-related variables
mITT and PP analyses of mean differences in participant-reported emotional regulation between PSYCHOPATHY.COMP and TAU groups. Measured with the Compassion Scale (CS): a 16-item self-report questionnaire measuring compassion towards others, composed of subscales representing kindness (4 items), common humanity (4 items), mindfulness (4 items), and indifference (4 items). Items are rated on a five-point Likert-type scale, ranging from 1: "Almost never" to 5: "Almost always". Scores are computed by averaging item responses (after correcting for reversed items), with higher scores indicating higher levels of compassion for others.
Mediation Testing: participant-reported compassion-related variables
mITT and PP analyses of mean differences in participant-reported emotional regulation between PSYCHOPATHY.COMP and TAU groups. Measured with the Fears of Compassion Scales (FCS): a 38-item self-report questionnaire that comprises three scales measuring: Fears of expressing compassion for others (10 items); Fears of receiving compassion from others (13 items), and Fears of compassion for self (15 items). Items are rated on a five-point Likert-type scale from 0 "Don't agree at all" to 4: "Completely agree". Scores are computed by averaging item responses, with higher scores indicating greater fears of compassion in the respective dimension.
Moderation Testing: participant-reported personality pathology pre-treatment
mITT and PP analyses of mean differences in personality pathology between PSYCHOPATHY.COMP and TAU groups. Measured with the Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II): a semi-structured diagnostic interview assessing Axis II personality disorders from the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV), and the depressive and passive-aggressive personality disorders (included in DSM-IV's appendix). It can be used to diagnose personality disorders categorically (present/absent) and dimensionally (according to the number of criteria met for each diagnosis) and is considered the "gold standard" for Personality Disorders diagnosis. The SCID-II also provides a summary with a pathology profile of scores over the assessed Personality Disorders.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Coimbra
Lead sponsor
European Regional Development Fund
Collaborator
Portuguese National Funding Agency for Science, Research and Technology (FCT)
Collaborator